Literature DB >> 30885660

The Hypotonic Environmental Changes Affect Liposomal Formulations for Nose-to-Brain Targeted Drug Delivery.

Iren Yeeling Wu1, Trygg Einar Nikolaisen1, Nataša Škalko-Basnet1, Massimiliano Pio di Cagno2.   

Abstract

Systemic administration of drugs is ineffective in the treatment of central nervous system disorders because of the blood-brain barrier. Nasal administration has been suggested as an alternative administration route as drugs absorbed in the olfactory epithelium bypass the blood-brain barrier and reach the brain within minutes. However, the nasal mucosa properties (e.g., tonicity, pH) are not constant because of physiological and environmental factors, and this might limit the therapeutic outcome of nanocarrier-based formulations. To shine light on the impact of environmental ionic strength on nanocarrier-based formulations, we have studied how liposomal formulations respond to the change of tonicity of the external environment. Large unilamellar vesicles loaded with 6 different drugs were exposed to different hypotonic environments, creating an osmotic gradient within the inner core and external environment of the liposomes up to 650 mOsm/kg. Both size and polydispersity of liposomes were significantly affected by tonicity changes. Moreover, the release kinetics of hydrophilic and lipophilic drugs were largely enhanced by hypotonic environments. These results clearly demonstrate that the environmental ionic strength has an impact on liposomal formulation stability and drug release kinetics and it should be considered when liposomal formulations for nose-to-brain targeted drug delivery are designed.
Copyright © 2019 American Pharmacists Association®. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  controlled release; drug delivery system; drug transport; liposomes; membrane resistance; osmotic pressure; particle size; passive diffusion

Year:  2019        PMID: 30885660     DOI: 10.1016/j.xphs.2019.03.006

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  5 in total

Review 1.  Nose to brain delivery of antiretroviral drugs in the treatment of neuroAIDS.

Authors:  Anupam Sarma; Malay K Das
Journal:  Mol Biomed       Date:  2020-12-10

2.  A stepwise-targeting strategy for the treatment of cerebral ischemic stroke.

Authors:  Jingbo Hu; Xueying Tan; Dongwei Wang; Yixuan Li; Hongze Liang; Jiejun Peng; Fengyan Li; Quan Zhou; Peiwu Geng; Shuanghu Wang; Yue Yu; Jin Liu
Journal:  J Nanobiotechnology       Date:  2021-11-17       Impact factor: 9.429

Review 3.  Lipid-Based Nanocarriers for Neurological Disorders: A Review of the State-of-the-Art and Therapeutic Success to Date.

Authors:  Bwalya Angel Witika; Madan Sai Poka; Patrick Hulisani Demana; Scott Kaba Matafwali; Siyabonga Melamane; Sandile Maswazi Malungelo Khamanga; Pedzisai Anotida Makoni
Journal:  Pharmaceutics       Date:  2022-04-11       Impact factor: 6.525

Review 4.  Liposomal Formulations for Nose-to-Brain Delivery: Recent Advances and Future Perspectives.

Authors:  Soon-Seok Hong; Kyung Taek Oh; Han-Gon Choi; Soo-Jeong Lim
Journal:  Pharmaceutics       Date:  2019-10-17       Impact factor: 6.321

5.  Development of Lomustine and n-Propyl Gallate Co-Encapsulated Liposomes for Targeting Glioblastoma Multiforme via Intranasal Administration.

Authors:  Gábor Katona; Fakhara Sabir; Bence Sipos; Muhammad Naveed; Zsuzsanna Schelz; István Zupkó; Ildikó Csóka
Journal:  Pharmaceutics       Date:  2022-03-12       Impact factor: 6.321

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.